Successful Metabolic support UK Conference

On Saturday, Medialis presented the flagship not-for-profit study investigating disease progression and quality of life in X-linked Hypophosphataemia, at the Metabolic Support UK’s Annual Conference: Improving Patient Access to Specialist Services and Treatments.

 

Designed and sponsored, in its entirety, by Medialis, with the support and valuable insights of Metabolic Support UK, this study was approved on a voluntary basis by the UK’s independent research ethics committee (NHS Health Research Authority) in June 2019. This study is the first of an exciting pipeline of patient-focused research projects under development by our highly experienced Real World Evidence (RWE) Team, with expertise in multi-phase study design and study conduct throughout Europe.

Recruitment to the study is now open and detailed information about participation can be obtained by contacting our dedicated RWE Team at [email protected].

We look forward to be able to provide further updates on recruitment and other progress in the coming months…